Lymphoid neogenesis in melanoma: What does it tell us?

OncoImmunology

Volumn 2, Issue 1, 2013, Pages

  van Baren, Nicolas ^a,b,c   Baurain, Jean François ^b   Coulie, Pierre G ^c  

^a LUDWIG INSTITUTE FOR CANCER RESEARCH   (Belgium)

^b CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^c DE DUVE INSTITUTE   (Belgium)

Author keywords

Ectopic lymphoid structures; Germinal center; Humoral response; IgA; Lymphoid neogenesis; Melanoma; Metastasis

Indexed keywords

CANCER VACCINE; CELL ADHESION MOLECULE; CHEMOKINE RECEPTOR; IMMUNOGLOBULIN A; MELANOMA ANTIGEN; MONOCLONAL ANTIBODY; TUMOR ANTIGEN;

ADAPTIVE IMMUNITY; ARTICLE; B LYMPHOCYTE ACTIVATION; CANCER MORPHOLOGY; CANCER PROGNOSIS; CANCER RESISTANCE; ENDOTHELIUM CELL; HUMAN; LYMPH NODE METASTASIS; LYMPHOCYTE PROLIFERATION; LYMPHOCYTIC INFILTRATION; LYMPHOID NEOGENESIS; MELANOMA; NONHUMAN; ORGANOGENESIS; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; TISSUE REGENERATION; TUMOR ASSOCIATED LEUKOCYTE; TUMOR MICROENVIRONMENT;

EID: 84886944489     PISSN: 21624011     EISSN: 2162402X     Source Type: Journal    
DOI: 10.4161/onci.22505     Document Type: Article

References (8)

1. Cipponi A, Mercier M, Seremet T, Baurain JF, Théate I, van den Oord J, et al. Neogenesis of lymphoid structures and antibody responses occur in human melanoma metastases. Cancer Res 2012; 72:3997-4007; PMID:22850419; http://dx.doi.org/10.1158/0008-5472.CAN-12-1377.
2. Neyt K, Perros F, GeurtsvanKessel CH, Hammad H, Lambrecht BN. Tertiary lymphoid organs in infection and autoimmunity. Trends Immunol 2012; 33:297-305; PMID:22622061; http://dx.doi.org/10.1016/j. it.2012.04.006.
3. van der Bruggen P, Traversari C, Chomez P, Lurquin C, De Plaen E, Van den Eynde B, et al. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 1991; 254:1643-7; PMID:1840703; http://dx.doi.org/10.1126/science. 1840703.
4. Boon T, Coulie PG, Van den Eynde BJ, van der Bruggen P. Human T cell responses against melanoma. Annu Rev Immunol 2006; 24:175-208; PMID:16551247; http://dx.doi.org/10.1146/annurev. immunol.24.021605.090733.
5. de Chaisemartin L, Goc J, Damotte D, Validire P, Magdeleinat P, Alifano M, et al. Characterization of chemokines and adhesion molecules associated with T cell presence in tertiary lymphoid structures in human lung cancer. Cancer Res 2011; 71:6391-9; PMID:21900403; http://dx.doi.org/10.1158/0008-5472.CAN-11-0952.
6. Fridman W-H, Pagès F, Sautès-Fridman C, Galon J. The immune contexture in human tumours: impact on clinical outcome. Nat Rev Cancer 2012; 12:298-306; PMID:22419253; http://dx.doi.org/10.1038/nrc3245.
7. Dieu-Nosjean M-C, Antoine M, Danel C, Heudes D, Wislez M, Poulot V, et al. Long-term survival for patients with non-small-cell lung cancer with intratumoral lymphoid structures. J Clin Oncol 2008; 26:4410-7; PMID:18802153; http://dx.doi. org/10.1200/JCO.2007.15.0284.
8. Martinet L, Garrido I, Filleron T, Le Guellec S, Bellard E, Fournie JJ, et al. Human solid tumors contain high endothelial venules: association with T- and B-lymphocyte infiltration and favorable prognosis in breast cancer. Cancer Res 2011; 71:5678-87; PMID:21846823; http://dx.doi.org/10.1158/0008-5472.CAN-11-0431.